SZSE:301211 (China)
Â
Class A
Â¥
17.11
(+0.47%)
May 24
Current and historical daily PE Ratio for Hubei Biocause Heilen Pharmaceutical Co Ltd (
SZSE:301211
) from 2021 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Hubei Biocause Heilen Pharmaceutical stock (SZSE:301211) PE ratio as of May 26 2024 is 28.52.
More Details
Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) PE Ratio (TTM) Chart
Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 586
- 1
- 2
- 3
- 4
- 5
- 6
- 7
| Hubei Biocause Heilen Pharmaceutical PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-26 | 28.5 | 2024-03-18 | 31.1 |
| 2024-05-24 | 28.5 | 2024-03-15 | 30.7 |
| 2024-05-23 | 28.4 | 2024-03-14 | 30.6 |
| 2024-05-22 | 29.2 | 2024-03-13 | 30.5 |
| 2024-05-21 | 29.1 | 2024-03-12 | 30.9 |
| 2024-05-20 | 29.6 | 2024-03-11 | 29.5 |
| 2024-05-17 | 29.1 | 2024-03-08 | 28.8 |
| 2024-05-16 | 29.2 | 2024-03-07 | 28.5 |
| 2024-05-15 | 29.6 | 2024-03-06 | 29.2 |
| 2024-05-14 | 30.1 | 2024-03-05 | 29.3 |
| 2024-05-13 | 30.0 | 2024-03-04 | 30.3 |
| 2024-05-10 | 30.2 | 2024-03-01 | 29.6 |
| 2024-05-09 | 31.1 | 2024-02-29 | 29.2 |
| 2024-05-08 | 32.0 | 2024-02-28 | 28.3 |
| 2024-05-07 | 30.8 | 2024-02-27 | 30.4 |
| 2024-05-06 | 30.1 | 2024-02-26 | 29.6 |
| 2024-04-30 | 29.1 | 2024-02-23 | 29.5 |
| 2024-04-29 | 28.6 | 2024-02-22 | 29.3 |
| 2024-04-26 | 28.3 | 2024-02-21 | 28.7 |
| 2024-04-25 | 28.1 | 2024-02-20 | 28.9 |
| 2024-04-24 | 27.9 | 2024-02-19 | 27.8 |
| 2024-04-23 | 27.8 | 2024-02-08 | 27.2 |
| 2024-04-22 | 27.4 | 2024-02-07 | 25.8 |
| 2024-04-19 | 27.1 | 2024-02-06 | 25.8 |
| 2024-04-18 | 27.1 | 2024-02-05 | 24.3 |
| 2024-04-17 | 27.4 | 2024-02-02 | 25.7 |
| 2024-04-16 | 25.9 | 2024-02-01 | 27.3 |
| 2024-04-15 | 27.7 | 2024-01-31 | 27.2 |
| 2024-04-12 | 28.3 | 2024-01-30 | 28.6 |
| 2024-04-11 | 28.6 | 2024-01-29 | 29.9 |
| 2024-04-10 | 28.9 | 2024-01-26 | 30.5 |
| 2024-04-09 | 29.9 | 2024-01-25 | 31.1 |
| 2024-04-08 | 28.8 | 2024-01-24 | 30.2 |
| 2024-04-03 | 29.8 | 2024-01-23 | 30.0 |
| 2024-04-02 | 29.9 | 2024-01-22 | 29.8 |
| 2024-04-01 | 30.5 | 2024-01-19 | 31.3 |
| 2024-03-29 | 29.7 | 2024-01-18 | 32.1 |
| 2024-03-28 | 30.0 | 2024-01-17 | 32.8 |
| 2024-03-27 | 29.4 | 2024-01-16 | 33.4 |
| 2024-03-26 | 29.3 | 2024-01-15 | 33.3 |
| 2024-03-25 | 29.0 | 2024-01-12 | 33.3 |
| 2024-03-22 | 30.0 | 2024-01-11 | 33.7 |
| 2024-03-21 | 30.9 | 2024-01-10 | 33.0 |
| 2024-03-20 | 31.4 | 2024-01-09 | 33.7 |
| 2024-03-19 | 31.0 | 2024-01-08 | 33.8 |
Hubei Biocause Heilen Pharmaceutical Co Ltd (SZSE:301211) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Hubei Biocause Heilen Pharmaceutical Co Ltd
ISIN : CNE100005782
Share Class Description:
SZSE:301211: Class ACompare
Compare
Traded in other countries / regions
301211.China IPO Date
2021-12-22Description
Hubei Biocause Heilen Pharmaceutical Co Ltd is engaged in the research and development, production and sales of chemical raw materials and preparation products.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers